Question 1

What is the catalog number for MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued?

Accepted Answer

The catalog number for MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued is 031102-ML405.

Question 2

What sizes are available for MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued?

Accepted Answer

MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued is available in the following size(s): 100 µL.

Question 3

Is MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued in stock?

Accepted Answer

MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

MAP2 (Microtubule-associated protein 2, MAP-2) (MaxLight 405) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Potassium Orotate

Water Bath BBWA-2401

TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF488A conjugate, 0.1mg/mL

Muscle Specific Actin (HHF35), CF568 conjugate, 0.1mg/mL

Convallatoxin

ADRM1 Polyclonal Antibody